Ticker Details
Xeris Pharmaceuticals, Inc.
IPO Date:	June 22, 2018
Sector:	Healthcare
Market Cap:	$1.49B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 3.68%
Avg Daily Range (30 D):	$0.18 | 2.60%
Avg Daily Range (90 D):	$0.17 | 2.64%

Institutional Daily Volume
Avg Daily Volume:	1.49M
Avg Daily Volume (30 D):	1.64M
Avg Daily Volume (90 D):	1.6M

Trade Size
Avg Trade Size (Sh.):	201
Avg Trade Size (Sh.) (30 D):	100
Avg Trade Size (Sh.) (90 D):	105

Institutional Trades
Total Institutional Trades:	649
Avg Institutional Trade:	$1.76M
Avg Institutional Trade (30 D):	$2.48M
Avg Institutional Trade (90 D):	$1.72M
Avg Institutional Trade Volume:	.32M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.9M
Avg Closing Trade (30 D):	$3.02M
Avg Closing Trade (90 D):	$1.89M
Avg Closing Volume:	328.36K

News

Aug 7, 2025 @ 3:55 PM Xeris (XERS) Q2 Revenue Jumps 49% Source: Jesterai

May 9, 2024 @ 12:10 PM Xeris Biopharma (XERS) Reports Q1 Loss, Lags Reven... Source: Zacks Equity Research

Apr 17, 2024 @ 11:24 AM Strength Seen in MediWound (MDWD): Can Its 14.3% J... Source: Zacks Equity Research

Mar 30, 2024 @ 5:28 AM Xeris Biopharma: Checking-In On One Of My 'Top Ide... Source: Biologics

Mar 5, 2024 @ 2:42 PM Why Xeris (XERS) Might Surprise This Earnings Seas... Source: Zacks Equity Research

Financials
	TTM	FY 2026	Q3 2026
Basic EPS	$.01
Diluted EPS	$.01
Revenue	$83.13M
Gross Profit
Net Income / Loss	$2.23M
Operating Income / Loss	$7.92M
Cost of Revenue
Net Cash Flow	$.71M
PE Ratio